Kailera to showcase obesity drug research at ObesityWeek 2026
Kailera Therapeutics will present new clinical and real-world research at ObesityWeek 2026, scheduled November 14-17 in Washington, D.C., the company announced. Presentations include the rationale and design of the Phase 3 KaiNETIC-1 and -2 trials and the KaiNETIC-3 trial for people with obesity wit
<p>Kailera Therapeutics will present new clinical and real-world research at ObesityWeek 2026, scheduled November 14-17 in Washington, D.C., the company announced. Presentations include the rationale and design of the Phase 3 KaiNETIC-1 and -2 trials and the KaiNETIC-3 trial for people with obesity wit</p>